Open AccessCost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients
Author(s) -
Anuj Shah,
Anand R. Shewale,
Corey J. Hayes,
Bradley C. Martin
Publication year - 2016
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.115.012325
Subject(s) - medicine , apixaban , atrial fibrillation , warfarin , dabigatran , stroke (engine) , rivaroxaban , edoxaban , cost effectiveness , quality adjusted life year , population , cohort , cardiology , intensive care medicine , mechanical engineering , risk analysis (engineering) , environmental health , engineering
The objective of the study is to compare the cost-effectiveness of oral anticoagulants among atrial fibrillation patients at an increased stroke risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom